Abstract
To the Editor:
The recently published study by Said and colleagues expressed concern with the Inspiris Resilia (IR) bioprosthesis (Edwards Lifescience LLC) in the pulmonary position. Of the reported cohort of 27 patients, 13 patients progressed to pulmonary regurgitation (PR) with a median time to appearance of 8 months postoperatively. Moderate or severe PR was present in 33% of the patients at 16 months...
The recently published study by Said and colleagues expressed concern with the Inspiris Resilia (IR) bioprosthesis (Edwards Lifescience LLC) in the pulmonary position. Of the reported cohort of 27 patients, 13 patients progressed to pulmonary regurgitation (PR) with a median time to appearance of 8 months postoperatively. Moderate or severe PR was present in 33% of the patients at 16 months...
Original language | English |
---|---|
Pages (from-to) | 651 |
Number of pages | 1 |
Journal | Annals of Thoracic Surgery |
Volume | 116 |
Issue number | 3 |
DOIs | |
Publication status | Published - Sept 2023 |
Externally published | Yes |
Keywords
- cardiac disease
- thoracic surgery